China SXT Pharmaceuticals Inc.

SXTC | NASDAQ

Price Alert Chart Builder DCF Calculator

$2.47

+$0.09 (+3.78%)

At close: Sep 22, 2026, 4:00 PM ET

$2.45

-$0.02 (-0.81%)

After-hours: Sep 22, 2026, 7:48 PM ET

Overview Rating Statistics Financials Earnings Analysts Ownership Profile

+3.78%

(1D)

Rating

Updated: Aug 18, 2026

Fundamentals Weak

Market Sentiment Neutral

Moat None

Full Analysis

Key Statistics

Market Data

Market Cap $1.32M

1D Range

2.30 2.49

52W Range

1.78 83,760

Valuation (TTM)

PE -0.30

PB 0.04

EV/EBITDA 3.51

Valuation (NTM)

Forward PE N/A

Forward PEG 0.00

Price Target N/A

Cash Flow

FCF Yield -410.4%

SBC Adj. FCF Yield -395.7%

SBC Impact -3.6%

Margins

Gross Margin 44.4%

Operating Margin -361.2%

FCF Margin -247.5%

Growth (CAGR)

Revenue 3Y | 5Y -32.2% | -21.5%

Dil EPS 3Y | 5Y 67.1% | 78.2%

FCF 3Y | 5Y -57.0% | -41.8%

Returns

ROA -21.2%

ROE -31.0%

ROIC -23.3%

Financial Health

Net Cash

$27.11M

Current Ratio 7.93

Interest Coverage -27.39

Dividends

Div Yield N/A

Payout Ratio N/A

FCF Payout Ratio N/A

All Key Statistics

Loading financial charts...

Profile

China SXT Pharmaceuticals, Inc., a pharmaceutical company, engages in the research, development, manufacture, marketing, and sale of traditional Chinese medicine pieces (TCMP) in China. The company of...

Sector Healthcare

Industry Drug Manufacturers - Specialty & Generic

Employees 56

IPO Date Jan 3, 2019

Website www.sxtchina.com

Fiscal Year April - March

Full Company Profile

Latest News

No news articles available yet.